Influensa
Senast reviderad:
Sakkunnig:Remy Waardenburg
Definition:
Akut luftvägsinfektion som orsakas av influensavirus A eller B, huvudsakligen aerosol smitta.
Förekomst:
Säsongsepidemier, incidens varierar från år till år.
Symtom:
Hastigt insjuknande, hög feber, frossa, muskelsmärtor, irritation i näsa och svalg, hosta, eventuellt kräkningar (särskilt hos barn)
Kliniska fynd:
Feber, rodnad i svalget och nedsatt allmäntillstånd.
Diagnostik:
Typisk klinisk bild under epidemier, eventuellt CRP. I vissa fall provtagning för influensa (PCR), om det påverkar den kliniska handläggningen.
Behandling:
Förebyggande behandling med vaccin årligen till riskgrupper inklusive alla >65 år och gravida. Antiviral behandling till alla i riskgrupp (oavsett vaccinationsstatus), vid risk för svår influensa, vid tecken på svår influensa eller som postexpositionsprofylax.
- Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003; 362: 1733-45. PubMed
- Hayward AC, Fragaszy EB, Bermingham A, et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. Lancet Respiratory Medicine 2014. doi: 10.1016/S2213-2600(14)70034-7. DOI
- Jefferson T. How to deal with influenza?. BMJ 2004; 329: 634-5. PubMed
- World Health Organization. Fifty-Sixth World Health Assembly. Prevention and control of influenza pandemics and annual epidemics (agenda item 14.14). Geneva: WHO, 26 May 2003.
- Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2017 Dec 13. PMID: 29248255.
- Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K. Systematic review and economic decision modeling for the prevention and treatment of influenza A and B. http://www.nice.org.uk/pdf/ influenzaassrep.pdf (accessed Oct 15, 2003).
- Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005; 353: 1363-73. PubMed
- Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database of Systematic Reviews 2014, Issue 4. Art. No.: CD008965. DOI: 10.1002/14651858.CD008965.pub4. DOI
- Dugas AF, Valsamakis A, Atreya MR, et al. Clinical diagnosis of influenza in the ED. Am J Emerg Med 2015 Jun; 33:770. PMID: 25827595 PubMed
- Merckx J, Wali R, Schiller I, et al. Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction: A Systematic Review and Meta-analysis. Ann Intern Med 2017. pmid:28869986 PubMed
- Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza. Clin Infect Dis 2018. pmid:30566567 PubMed
- Läkemedelsverket. Behandlingsrekommendation: Behandling och profylax vid influensa. Uppsala, juni 2022. lakemedelsverket.se
- Dobson J, Whitley RJ, Pocock S, et al. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015 May 2;385(9979):1729-37 . pmid:25640810 PubMed
- Louie JK, Lampiris H. Treating Influenza With Neuraminidase Inhibitors: What Is the Evidence? JAMA Intern Med. 2015 Dec;175(12):1899-900. PubMed
- Butler CC, van der Velden AW, Bongard E, et al. Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial. Lancet. 2019. PMID: 31839279 PubMed
- Heneghan CJ, Onakpoya I, Joes MA, et al. Neuraminidase inhibitors for influenza: a systematic review and meta-analysis of regulatory and mortality data. Health Technol Assess 2016. PMID: 27246259 PubMed
- Jefferson T, Jones M, Doshi P, et al. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ. 2014 Apr 9;348:g2545. doi: 10.1136/bmj.g2545. DOI
- Jefferson T1, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014 Apr 10;4:CD008965. DOI: 10.1002/14651858.CD008965.pub4. DOI
- Graner S, Smith T, Beau en pike-Michel C, et al. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study. BMJ 2017; 356: j629.. doi:10.1136/bmj.j629 DOI
- Hung IFN, To KKW, Chan JFW, et al. Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A(H3N2) infection: An open-label randomized, controlled, phase IIb/III trial. Chest 2017 May; 151: 1069. pmid:27884765 PubMed
- Jefferson T, Del Mar C, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ 2009; 339: b3675. BMJ (DOI)
- Behandling av och profylax mot influensa med antivirala medel - uppdaterad rekommendation. Läkemedelsverket 2011. www.lakemedelsverket.se
- Rekommendationer om influensavaccination till riskgrupper. Folkhälsomyndigheten 2020. www.folkhalsomyndigheten.se
- Scuffham PA, West PA. Economic evaluation of strategies for the control and management of influenza in Europe. Vaccine 2002;20: 2562-78. PubMed
- Cates CJ, Jefferson TO, Bara AI, Rowe BH. Vaccines for preventing influenza in people with asthma (Cochrane Review): In. The Cochrane Library; Issue 4, 2000. Oxford Update Software. The Cochrane Library
- Luftvägsinfektioner i öppen vård. Strama/Janusinfo Stockholms Länd Landsting. Hämtad 2017-10-24. www.janusinfo.se
- Estabragh ZR, Mamas MA. The cardiovascular manifestations of influenza: a systematic review. Int J Cardiol. 2013 Sep 10;167(6):2397-403. doi: 10.1016/j.ijcard.2013.01.274.
- Folkhälsomyndigheten. Sammanfattande rapport för säsongen 2017-2018. (2018-07-06) hämtad 2019-01-29. www.folkhalsomyndigheten.se
- Influensarapport. Folkhälsomyndigheten 2020. www.folkhalsomyndigheten.se
- Remy Waardenburg, specialist i allmänmedicin, medicinsk redaktör Medibas